Skip to main content
. 2021 Aug 24;6:107. doi: 10.1038/s41541-021-00365-w

Fig. 2. RBM displayed on the surface of mCuMVTT-MERS vaccine binds human receptor DPP4.

Fig. 2

DPP4 binding of mCuMVTT-MERS vaccine candidate and CuMVTT as a control. Plates coated with 1 μg/ml of DPP4. Binding revealed with an anti-CuMV mAb. One representative of three similar experiments is shown.